United Therapeutics Corporation (UTHR)
Add to Watchlists Create an Alert
67.61
-0.21 -0.31%
NASDAQ
May 23, 8:00PM
BATS Real time
Currency in USD
United Therapeutics Corporation Return on Equity:
27.77% for March 31, 2013United Therapeutics Corporation Historical Return on Equity Data
Pro Data Export
Dates:
to
There is no data for the selected date range.
| Data for this Date Range | |
|---|---|
| March 31, 2013 | 27.77% |
| Dec. 31, 2012 | 29.69% |
| Sept. 30, 2012 | 25.78% |
| June 30, 2012 | 26.69% |
| March 31, 2012 | 27.31% |
| Dec. 31, 2011 | 22.49% |
| Sept. 30, 2011 | 19.45% |
| June 30, 2011 | 15.74% |
| March 31, 2011 | 12.43% |
| Dec. 31, 2010 | 13.62% |
| Sept. 30, 2010 | 12.77% |
| June 30, 2010 | 9.57% |
| March 31, 2010 | 3.93% |
| Dec. 31, 2009 | 3.21% |
| Sept. 30, 2009 | -10.60% |
| June 30, 2009 | -11.96% |
| March 31, 2009 | -9.72% |
| Dec. 31, 2008 | -11.58% |
| Sept. 30, 2008 | 11.98% |
| June 30, 2008 | 15.48% |
| March 31, 2008 | Go Pro |
| Dec. 31, 2007 | Go Pro |
| Sept. 30, 2007 | Go Pro |
| June 30, 2007 | Go Pro |
| March 31, 2007 | Go Pro |
| Dec. 31, 2006 | Go Pro |
| Sept. 30, 2006 | Go Pro |
| June 30, 2006 | Go Pro |
| March 31, 2006 | Go Pro |
| Dec. 31, 2005 | Go Pro |
| Sept. 30, 2005 | Go Pro |
| June 30, 2005 | Go Pro |
| March 31, 2005 | Go Pro |
| Dec. 31, 2004 | Go Pro |
| Sept. 30, 2004 | Go Pro |
| June 30, 2004 | Go Pro |
| March 31, 2004 | Go Pro |
| Dec. 31, 2003 | Go Pro |
| Sept. 30, 2003 | Go Pro |
| June 30, 2003 | Go Pro |
| March 31, 2003 | Go Pro |
| Dec. 31, 2002 | Go Pro |
| Sept. 30, 2002 | Go Pro |
| June 30, 2002 | Go Pro |
| March 31, 2002 | Go Pro |
| Dec. 31, 2001 | Go Pro |
| Sept. 30, 2001 | Go Pro |
| June 30, 2001 | Go Pro |
| March 31, 2001 | Go Pro |
| Dec. 31, 2000 | Go Pro |
About Return on Equity (ROE)
Return on equity (ROE) measures the rate of return on the money invested by common stock owners and retained by the company thanks to previous profitable years. It demonstrates a company's ability to generate profits from shareholders' equity (also known as net assets or assets minus liabilities).
ROE shows how well a company uses investment funds to generate growth. Return on equity is useful for comparing the profitability of companies within a sector or industry.
Investors generally are interested in company's that have high, increasing returns on equity.
Learn More
UTHR Return on Equity Benchmarks
| Companies | |
|---|---|
| Pluristem Therapeutic | -32.64% |
| Celgene Corporation | 24.81% |
| Lannett Company | 7.98% |
UTHR Return on Equity Rankings
| Overall |
95th percentile 397 of 8006 |
| Sector |
95th percentile 30 of 686 in Healthcare |
| Industry |
95th percentile 12 of 248 in Biotechnology |
UTHR Return on Equity Range, Past 5 Years
| Minimum | -11.96% | Jun 2009 |
| Maximum | 29.69% | Dec 2012 |
| Average | 11.70% |
